Company profile for Sequana Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. Over 900 a...
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. Over 900 alfapump® systems have been implanted. The alfapump® has been endorsed by key independent third parties in Europe and has received Breakthrough Device status from the US FDA.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Technologiepark 122 9052, Zwijnaarde
Telephone
Telephone
+32 9 292 8065
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/05/3200890/0/en/SEQUANA-MEDICAL-ANNOUNCES-NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES.html

GLOBENEWSWIRE
05 Dec 2025

https://www.globenewswire.com/news-release/2025/11/24/3193800/0/en/Press-release-Transparency-Notification-from-Shareholders.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/24/3193184/0/en/Sequana-Medical-Announces-First-U-S-Commercial-alfapump-Implantation-at-Mount-Sinai-Hospital-in-New-York.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/20/3192234/0/en/SEQUANA-MEDICAL-ANNOUNCES-THE-ISSUANCE-OF-A-SUBSCRIPTION-REQUEST-NOTICE-UNDER-THE-SHARE-SUBSCRIPTION-FACILITY-AGREEMENT-WITH-GEM.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/14/3188484/0/en/SEQUANA-MEDICAL-ANNOUNCES-NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/10/16/3168164/0/en/Press-release-NEW-SHARE-CAPITAL-AMOUNT-AND-NEW-NUMBER-OF-SHARES-ISSUANCE-OF-A-NEW-SUBSCRIPTION-REQUEST-NOTICE-UNDER-THE-SHARE-SUBSCRIPTION-FACILITY-AGREEMENT-WITH-GEM.html

GLOBENEWSWIRE
16 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty